Astellas Bulgaria

Most Recent Disclosure Reports
Previous Disclosure Reports

2017 Astellas Transparency Disclosure Report

Astellas is a member company of the European Federation of Pharmaceutical Industries and Associations (“EFPIA”) and adheres to the EFPIA Disclosure Code 2014 (the “EFPIA Disclosure Code”).

The EFPIA Disclosure Code requires all member companies to document and disclose certain Transfers of Value they make, directly or indirectly, to or for the benefit of, Healthcare Professionals (“HCPs”) or Healthcare Organisations (“HCOs”) (“Disclosures”).

The EFPIA Disclosure Code is implemented in Bulgaria by the Association of the Research-Based Pharmaceutical Manafacturers in Bulgaria (ARPharM).  Astellas discloses all Transfers of Value to HCPs and HCOs in accordance with its commitment to the EFPIA Disclosure Code and any applicable Bulgarian national code.

Disclaimer: Publication of transfers of value to Recipients aims at reporting the values (monetary or in-kind) to HCPs/HCOs our company is collaborating / has relationships with, following the objectives and provisions included in the applicable codes.  Individual disclosures have been consented to by individual Recipients – such consent has been given to allow complying with the applicable codes that our company signed off to.

These publications do not grant a general permission for those accessing our website or the national platforms to undertake additional processing of the healthcare professionals’ data.

For a good understanding of the reporting included in our disclosures as published on this website, we refer to the Methodological Note that clarifies the meaning and content of the transfers of value reported.